Seoul, South Korea

Ji Hyun Lee

This inventor holds 1 USPTO granted patent. Top assignee: Kookmin University Industry Academy Cooperation Foundation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ji Hyun Lee. Retrieved from https://idiyas.com/inventor/ji-hyun-lee-yv971ewi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ji Hyun Lee: Inventor in Antibody Research

Introduction

Ji Hyun Lee is an inventor based in Seoul, South Korea. His patent work includes research related to antibodies targeting the SARS-CoV-2 spike protein.

Latest Patents

Lee is associated with 1 patent: “Antibody Binding Specifically to SARS-CoV-2 S Protein or Antigen-Binding Fragment Thereof, Bispecific Antibody, and Uses Thereof.” The invention concerns antibodies that bind specifically to the SARS-CoV-2 spike protein, including bispecific antibodies and their potential uses.

Career Highlights

Lee is associated with the Kookmin University Industry Academy Cooperation Foundation. The available information identifies his patent activity in antibody research but does not provide further details about his role or career history.

Collaborations

Lee’s listed coworkers include Sukmook Lee and Ji Woong Kim. Their names are associated with his professional network, though specific contributions to the patent are not provided here.

Conclusion

Ji Hyun Lee’s recorded invention focuses on antibody technologies targeting the SARS-CoV-2 spike protein, reflecting his connection to research and innovation in South Korea.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…